At the news
? NEUTRALIMPACT 3/10 EFFECT filed Mar 3, 2026 at 00:15 ET
Analysis based on filing metadata only, document content was unavailable. This is an EFFECT filing, indicating that a previously filed registration statement (likely a shelf registration) has become effective, allowing Prothena to issue securities immediately. No financial details or offering terms are available in the provided documents.
- EFFECT filing indicates a registration statement has become effective as of March 2, 2026
- SEC File Number: 333-277290, suggesting this relates to a prior Form S-3 or F-3 registration
- Company is based in Dublin, Ireland and operates in the life sciences sector
- No offering size, pricing, or use of proceeds disclosed in available documents
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access